1094 related articles for article (PubMed ID: 28322989)
1. Role of microRNAs in endocrine cancer metastasis.
Lima CR; Gomes CC; Santos MF
Mol Cell Endocrinol; 2017 Nov; 456():62-75. PubMed ID: 28322989
[TBL] [Abstract][Full Text] [Related]
2. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
Humphries B; Yang C
Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
[TBL] [Abstract][Full Text] [Related]
3. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
[TBL] [Abstract][Full Text] [Related]
4. The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells.
Zhang Z; Liu ZB; Ren WM; Ye XG; Zhang YY
Int J Mol Med; 2012 Oct; 30(4):856-62. PubMed ID: 22797360
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
7. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs: promising biomarkers for diagnosis and therapeutic targets in human colorectal cancer metastasis.
Hur K
BMB Rep; 2015 Apr; 48(4):217-22. PubMed ID: 25603797
[TBL] [Abstract][Full Text] [Related]
9. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
10. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.
Khella HW; Bakhet M; Allo G; Jewett MA; Girgis AH; Latif A; Girgis H; Von Both I; Bjarnason GA; Yousef GM
Carcinogenesis; 2013 Oct; 34(10):2231-9. PubMed ID: 23715501
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
13. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
Yang Z; Yuan Z; Fan Y; Deng X; Zheng Q
Mol Med Rep; 2013 Nov; 8(5):1353-8. PubMed ID: 24064622
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.
Zhang JP; Zeng C; Xu L; Gong J; Fang JH; Zhuang SM
Oncogene; 2014 Jul; 33(31):4069-76. PubMed ID: 24013226
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
Xu M; Qin S; Cao F; Ding S; Li M
Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR
PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297
[TBL] [Abstract][Full Text] [Related]
17. A family of pleiotropically acting microRNAs in cancer progression, miR-200: potential cancer therapeutic targets.
Zhang HF; Xu LY; Li EM
Curr Pharm Des; 2014; 20(11):1896-903. PubMed ID: 23888967
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in the thyroid.
Boufraqech M; Klubo-Gwiezdzinska J; Kebebew E
Best Pract Res Clin Endocrinol Metab; 2016 Oct; 30(5):603-619. PubMed ID: 27923454
[TBL] [Abstract][Full Text] [Related]
19. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.
Huang N; Wu Z; Lin L; Zhou M; Wang L; Ma H; Xia J; Bin J; Liao Y; Liao W
Oncotarget; 2015 Jun; 6(17):15222-34. PubMed ID: 25945841
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma.
Chu YH; Hardin H; Schneider DF; Chen H; Lloyd RV
Exp Mol Pathol; 2017 Oct; 103(2):229-236. PubMed ID: 29107050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
